Search Results
Dec 09, 2025, 14:24 ET Menarini Group 於 2025 年聖安東尼奧乳癌研討會公佈 Elacestrant (ORSERDU®) 針對 ER+、HER2- 轉移性乳癌 (mBC) 患者的第 2 期聯合治療數據
「令人鼓舞的無惡化存活期數據，增強了我們對 elacestrant 在聯合治療中作為內分泌治療骨幹角色的信心。」德州大學聖安東尼奧分校健康科學中心血液學/腫瘤科醫學教授兼德州大學聖安東尼奧分校 MD 安德森癌症中心乳癌項目負責人 Virginia Kaklamani 醫學博士表示， 「Elacestrant 與 everolimus 或 abemaciclib 聯合使用的安全性特徵，與每種藥物已知的安全性特徵一致。並未發現新的安全訊號。」將於 SABCS 發表的 ELEVATE
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 14:06 ET NCCN Summit Seeks to Improve Care for Veterans and First Responders with Cancer from Line-of-Duty Exposure
Summit on the unique cancer needs of veterans and first responders. It featured a fireside chat from Representative Mariannette Miller-Meeks, MD, MS (IA-01), a physician and veteran of the U.S. Army. The program also brought together a diverse group of experts to discuss how veterans, firefighters,
More news about: National Comprehensive Cancer Network
Dec 09, 2025, 14:00 ET For A Bright Future Foundation Announces 2025 STEM Scholarship Recipients
Laveriano.Morelia Gil Cubillo is pursuing Chemical Engineering at UC Berkeley. Passionate about medical research, Morelia aspires to become an MD/PhD specializing in senility prevention, focusing on stem cell therapy and protein engineering to combat Alzheimer's disease." This scholarship
More news about: Louis Hernandez Jr.'s Foundation For A Bright Future
Dec 09, 2025, 13:29 ET Alley Cat Rescue African Wildcat Conservation Program Achieves Domestic Cat Sterilization Milestone in South Africa
MT. RAINIER, Md., Dec. 9, 2025 /PRNewswire/ -- Alley Cat Rescue's African wildcat conservation program operates in South Africa to protect the unique wild cat species (Felis lybica) from hybridization with domestic cats
More news about: Alley Cat Rescue, Inc.
Dec 09, 2025, 13:09 ET Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026
Small Bowel and Hepatobiliary TractDate/Time: January 9th, 2026, at 11:30am-1pm (PST)First Author: Anwaar Saeed, MD, University of Pittsburgh Medical CenterABOUT SPEVATAMIGSpevatamig is a first-in-class native IgG-like bispecific antibody (bsAb)
More news about: Phanes Therapeutics, Inc.
Dec 09, 2025, 12:31 ET The Aesthetic Society Announces New Tagline: "The Gold Standard of Aesthetics"
trailblazers—visionary plastic surgeons who not only practiced aesthetic plastic surgery, but helped create the specialty itself," said Tracy Pfeifer, MD, MS, President of The Aesthetic Society. "That same pioneering spirit continues to guide The Aesthetic Society today. Our new tagline speaks clearly to
More news about: The Aesthetic Society
Dec 09, 2025, 12:02 ET New Book "HEAL" Introduces a Doctor-Designed Nutrition Blueprint to Help Patients Recover Faster from Surgery and Injury
https://www.prnewswire.com/news-releases/new-book-heal-introduces-a-doctor-designed-nutrition-blueprint-to-help-patients-recover-faster-from-surgery-and-injury-302636770.htmlSOURCE Parsa MD.
More news about: Parsa MD.
Dec 09, 2025, 12:00 ET TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.
accurate monitoring of uveal melanoma, enabling personalized care and improving patient managementROCKVILLE, Md. and ZURICH, Dec. 9, 2025 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision diagnostics,
More news about: TrilliumBiO
Dec 09, 2025, 11:38 ET El Grupo Menarini presenta datos de la combinación de fase 2 de Elacestrant (ORSERDU®) en cáncer de mama
DSc, profesora de Medicina en la División de Hematología/Oncología de UT Health San Antonio y jefa del Programa de Cáncer de Mama del Centro Oncológico MD Anderson de UT Health San Antonio. "El perfil de seguridad de elacestrant en combinación con everolimus o abemaciclib concuerda con los perfiles de seguridad
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 11:19 ET Journal of Cardiac Failure December Issue Showcases Innovations in Transplant Care, Digital Therapeutics, and Global Heart Failure Treatment Strategies
JCF co-editors-in-chief Robert J. Mentz, MD and Anuradha Lala, MD "These featured articles illustrate how innovation is happening on many fronts: in transplant medicine, digital therapeutics, and consensus-building
More news about: Heart Failure Society of America
Dec 09, 2025, 11:14 ET Regenerative Patch Technologies (RPT) Announces Treatment of First Two Patients in Phase IIb Clinical Trial Assessing the Safety and Efficacy of its Allogeneic Bioengineered RPE Cell Implant for the Treatment of Advanced Dry Age-Related Macular Degeneration.
implantation.""This is an important clinical trial in the development of treatments for geographic atrophy," stated Suber Huang, MD, MBA, FASRS and Chief Executive Officer of the Retina Center of Ohio. "To date, the only treatments available to patients with geographic atrophy involve
More news about: Regenerative Patch Technologies
Dec 09, 2025, 10:26 ET Westchester Medical Center and Good Samaritan Hospital Recognized as Top Maternity Hospitals by U.S. News & World Report
profound moments of their lives, and that responsibility drives us to deliver care at a level few health systems even attempt," said David Lubarsky, MD, MBA, President and Chief Executive Officer of WMCHealth. "This recognition affirms that WMCHealth is not only meeting that charge — we are redefining
More news about: Westchester Medical Center
Dec 09, 2025, 10:08 ET adoro, a New Kind of Pet Insurance, Launches in 28 States
by industry experts, has officially launched in 28 states across the country. adoro is currently live in AL, AR, AZ, CO, CT, DC, DE, GA, ID, IL, IN, MD, MI, MN, MO, NE, NV, NH, NM, NC, OH, OR, PA, TX, TN, UT, VA, and WI, with more coming soon. adoro plans to offer policies across the country.
More news about: adoro
Dec 09, 2025, 10:00 ET Georgia Patients Choose Atlanta Fibroid Center as Best Physician Practice in 2025
hysterectomy for women with uterine fibroids across Georgia. The award, presented by the Georgia Business Journal, highlights the leadership of John Lipman, MD, FSIR, one of the nation's most experienced physicians in uterine fibroid embolization, or UFE. This minimally invasive, revolutionary, outpatient
More news about: Atlanta Fibroid Center
Dec 09, 2025, 10:00 ET McCormick® Unveils the 2026 Flavor of the Year: Black Currant
Forecast® and is celebrating Black Currant throughout the year with launch events and product dropsHUNT VALLEY, Md., Dec. 9, 2025 /PRNewswire/ -- The future of flavor is here: McCormick unveils its
More news about: McCormick & Company
Dec 09, 2025, 09:49 ET 메나리니 그룹, 2025 샌안토니오 유방암 심포지엄에서 엘라세스트란트(ORSERDU)®의 ER+, HER2- 전이성 유방암(mBC) 환자 대상 2상 병용 요법 데이터 발표
버지니아 카클라마니(Virginia Kaklamani, MD, DSc) UT 헬스 샌안토니오(UT Health San Antonio) 혈액종양내과 교수이자 UT 헬스 샌안토니오 MD 앤더슨 암센터(UT Health San Antonio MD Anderson Cancer Center) 유방암 프로그램 책임자는 "고무적인 무진행 생존 데이터는 병용 요법 환경에서 엘라세스트란트(elacestrant)가 내분비 치료의 기반
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 09:30 ET Lung Cancer Research Foundation Announces Recipients of LCRF | Boehringer Ingelheim Early Investigator Awards
HER2 alterations drive cancer progression and contribute to both response and resistance," said LCRF's Chief Scientific Officer, Antoinette Wozniak, MD. "We are hopeful that these projects will yield discoveries that directly improve care for patients with HER2-altered tumors.""We're proud to support
More news about: Lung Cancer Research Foundation
Dec 09, 2025, 09:07 ET MedINT Launches First Human-in-the-Loop Medical AI Platform for Complex Clinical Decision-Making
commercially available to health systems, hospitals, and clinical partners. The company offers two service levels: a self-guided AI tool for clinicians and an MD-guided comprehensive literature review service for tumor boards and complex treatment decisions.About MedINTMedINT helps clinicians
More news about: Medint
Dec 09, 2025, 09:03 ET Sage Growth Partners Honored for Healthcare Marketing Campaign of the Year at 2025 PR Daily Awards
communications.Sage was in elite company, as the 2025 class of winners included work for powerful brands such as Coca-Cola, NBCUniversal, Disney Entertainment, MD Anderson Cancer Center, Merck, and the American Diabetes Association.For more information on Sage Growth Partners and their award-winning
More news about: Sage Growth Partners
Dec 09, 2025, 09:02 ET dtSearch® Adds Linux ARM64 Build to Engine, Making x64 and ARM64 Now Available for Windows, macOS and Linux; Document Filters Enhance JSON and CSV Support
across a wide range of online and offline data; products can run "on premises" or from the cloudBETHESDA, Md., Dec. 9, 2025 /PRNewswire/ --
More news about: dtSearch Corp.
Dec 09, 2025, 09:00 ET TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.
accurate monitoring of uveal melanoma, enabling personalized care and improving patient managementROCKVILLE, Md. and ZURICH, Dec. 9, 2025 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision diagnostics,
More news about: TrilliumBiO
Dec 09, 2025, 09:00 ET Parkinson's Foundation Names Centers of Excellence in Ohio and Wisconsin
us. It's the ultimate reflection of the dedication our entire team brings to caring for people with Parkinson's every single day," said Ariane Park, MD, MPH, Medical Director, The Ohio State University Wexner Medical Center's Center for Parkinson's Disease and Other Movement Disorders. "We've built something
More news about: Parkinson's Foundation
Dec 09, 2025, 09:00 ET Sibel Health Awarded a $500,000 Drug Development Tools Research Grant by the FDA for a Novel AI-Enabled Wearable Sensor for Scratch Monitoring
our technology with dozens of sponsors from Phase I to Phase IV trials to assess scratching in both AD and other pruritic conditions," says Steve Xu, MD, MSc, CEO of Sibel Health and PI of the grant.This FDA award represents a critical step toward establishing scratching behavior as a validated,
More news about: Sibel Health
Dec 09, 2025, 09:00 ET Turning Resolutions Into Reservations: 91% of Americans Plan To Travel in 2026, Marriott Bonvoy Survey Reveals
leading travel brand is giving five lucky winners a chance to win 1 million Marriott Bonvoy points.BETHESDA, Md., Dec. 9, 2025 /PRNewswire/ -- As Americans set their intentions for the new year, a recent survey¹ from hospitality
More news about: Marriott International, Inc.
Dec 09, 2025, 08:49 ET Baltimore's Monkey in the Metal Expands Capabilities With KSI Professional Acquisition and New 12,000 Sq. Ft. Facility
ksipro.com ContactNick ModhaMonkey in the Metal3403 Sinclair Lane, Baltimore, MD 21213Phone: 443-453-9625 Email: [email protected] Web:
More news about: Monkey in the Metal